

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 8.66557146 |
| 2 | negative T cell selection (GO:0043383) | 7.45141205 |
| 3 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 7.44308848 |
| 4 | positive T cell selection (GO:0043368) | 6.35829355 |
| 5 | T cell migration (GO:0072678) | 6.23583979 |
| 6 | tachykinin receptor signaling pathway (GO:0007217) | 6.21224437 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.05532664 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.75661198 |
| 9 | regulation of uterine smooth muscle contraction (GO:0070472) | 5.73335495 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.64680507 |
| 11 | interferon-gamma production (GO:0032609) | 5.35600681 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.24535017 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.16663319 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.16663319 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.15253461 |
| 16 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.06139494 |
| 17 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.99683622 |
| 18 | T cell receptor signaling pathway (GO:0050852) | 4.88602243 |
| 19 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.81932408 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.74398972 |
| 21 | protein K11-linked deubiquitination (GO:0035871) | 4.73394549 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.70357511 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.68799120 |
| 24 | thymic T cell selection (GO:0045061) | 4.68587451 |
| 25 | negative regulation of T cell apoptotic process (GO:0070233) | 4.59324676 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.42086477 |
| 27 | negative regulation of glycogen biosynthetic process (GO:0045719) | 4.41687367 |
| 28 | T cell selection (GO:0045058) | 4.40037624 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.33066692 |
| 30 | mast cell activation (GO:0045576) | 4.31899508 |
| 31 | leukocyte aggregation (GO:0070486) | 4.27449170 |
| 32 | positive regulation of granulocyte differentiation (GO:0030854) | 4.17289426 |
| 33 | negative regulation of stress fiber assembly (GO:0051497) | 4.15038844 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 4.14309819 |
| 35 | regulation of defense response to virus by virus (GO:0050690) | 4.03560335 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 4.03387389 |
| 37 | mitochondrial calcium ion transport (GO:0006851) | 4.02427738 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00247035 |
| 39 | mast cell activation involved in immune response (GO:0002279) | 3.98637311 |
| 40 | mast cell degranulation (GO:0043303) | 3.98637311 |
| 41 | actin nucleation (GO:0045010) | 3.90109562 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.83673649 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.83360313 |
| 44 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.75220741 |
| 45 | positive regulation of T cell cytokine production (GO:0002726) | 3.73657993 |
| 46 | response to interleukin-15 (GO:0070672) | 3.61634989 |
| 47 | adenosine metabolic process (GO:0046085) | 3.52147438 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.52059984 |
| 49 | regulation of energy homeostasis (GO:2000505) | 3.49978679 |
| 50 | regulation of regulatory T cell differentiation (GO:0045589) | 3.49758845 |
| 51 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.48008925 |
| 52 | purine-containing compound salvage (GO:0043101) | 3.47143083 |
| 53 | negative regulation of glycogen metabolic process (GO:0070874) | 3.44930572 |
| 54 | purine nucleotide salvage (GO:0032261) | 3.44541716 |
| 55 | regulation of T cell apoptotic process (GO:0070232) | 3.42628090 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.38527404 |
| 57 | positive regulation of smooth muscle contraction (GO:0045987) | 3.38444898 |
| 58 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.37170104 |
| 59 | lymphocyte migration (GO:0072676) | 3.31702107 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30580670 |
| 61 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.27429280 |
| 62 | T cell costimulation (GO:0031295) | 3.27300298 |
| 63 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.27139251 |
| 64 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.24699471 |
| 65 | lymphocyte costimulation (GO:0031294) | 3.23280739 |
| 66 | tongue development (GO:0043586) | 3.20623662 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.16199437 |
| 68 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.14495185 |
| 69 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.13778704 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.13778704 |
| 71 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.12961277 |
| 72 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12314056 |
| 73 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.12051165 |
| 74 | regulation of T cell differentiation in thymus (GO:0033081) | 3.10101790 |
| 75 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.09256248 |
| 76 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.09256248 |
| 77 | regulation of thymocyte apoptotic process (GO:0070243) | 3.06205211 |
| 78 | T cell differentiation (GO:0030217) | 3.05912507 |
| 79 | chemokine-mediated signaling pathway (GO:0070098) | 3.05706754 |
| 80 | alpha-beta T cell differentiation (GO:0046632) | 3.04189892 |
| 81 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.03968601 |
| 82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.03116852 |
| 83 | positive regulation of humoral immune response (GO:0002922) | 3.02758403 |
| 84 | cellular response to zinc ion (GO:0071294) | 3.02260728 |
| 85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00184519 |
| 86 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.99014616 |
| 87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98039855 |
| 88 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.97320032 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 2.97163114 |
| 90 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.94349608 |
| 91 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.93262459 |
| 92 | regulation of cell killing (GO:0031341) | 2.92296606 |
| 93 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.91395471 |
| 94 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.87312584 |
| 95 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.85673034 |
| 96 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.80256186 |
| 97 | positive regulation of T cell mediated immunity (GO:0002711) | 2.78412939 |
| 98 | positive regulation of cell killing (GO:0031343) | 2.76770393 |
| 99 | deoxyribose phosphate catabolic process (GO:0046386) | 2.75195418 |
| 100 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.70877740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.33438647 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.37196480 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.11139602 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.10173323 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.98413346 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.67918866 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35790294 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.03844853 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.01840899 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 2.72557179 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42435846 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.34470511 |
| 13 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.21453478 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15472905 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13485351 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.09575094 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05938505 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.05176107 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02961874 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94556909 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.81360574 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80677862 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80395765 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 1.78150856 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72863898 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.61396890 |
| 27 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.59383388 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54620092 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47962108 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45413798 |
| 31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43934280 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36729918 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34645779 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34409527 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32084136 |
| 36 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.25152855 |
| 37 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.23483706 |
| 38 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.22071294 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18766909 |
| 40 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17954551 |
| 41 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.16341043 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15910036 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11559312 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09737760 |
| 45 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08471674 |
| 46 | NFYA_21822215_ChIP-Seq_K562_Human | 1.08238801 |
| 47 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07321886 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07285562 |
| 49 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.06586438 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06078516 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05838374 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05101983 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04842919 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04402467 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03552020 |
| 56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03260096 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02657344 |
| 58 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01303242 |
| 59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00769274 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98740917 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98132597 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97820961 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97820961 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97349297 |
| 65 | P300_27268052_Chip-Seq_Bcells_Human | 0.95962648 |
| 66 | NCOR_22424771_ChIP-Seq_293T_Human | 0.95188314 |
| 67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94728545 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94690974 |
| 69 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.94012744 |
| 70 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.93982317 |
| 71 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.93472468 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90862291 |
| 73 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.89427263 |
| 74 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.89083119 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88849793 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87613089 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85798328 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85204255 |
| 79 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85084690 |
| 80 | NFYB_21822215_ChIP-Seq_K562_Human | 0.84102123 |
| 81 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83547841 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82941058 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82454055 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81509520 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81021337 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80722247 |
| 87 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.79743738 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74214124 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73904298 |
| 90 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73609427 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73531389 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72037184 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72037184 |
| 94 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.71688046 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70753097 |
| 96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.70683800 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.70432291 |
| 98 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.69414195 |
| 99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.69414195 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69186970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.45458388 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.77762765 |
| 3 | MP0003646_muscle_fatigue | 4.52566985 |
| 4 | MP0003878_abnormal_ear_physiology | 3.58637133 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.58637133 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.89538520 |
| 7 | MP0009785_altered_susceptibility_to | 2.75028684 |
| 8 | MP0003436_decreased_susceptibility_to | 2.32399654 |
| 9 | MP0005025_abnormal_response_to | 2.29549083 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.26401965 |
| 11 | MP0004381_abnormal_hair_follicle | 2.21663520 |
| 12 | MP0001800_abnormal_humoral_immune | 2.21613613 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.21510833 |
| 14 | MP0004043_abnormal_pH_regulation | 2.18893247 |
| 15 | MP0003786_premature_aging | 2.16138188 |
| 16 | MP0002102_abnormal_ear_morphology | 2.05870255 |
| 17 | MP0002723_abnormal_immune_serum | 2.04397465 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.03900310 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.03748314 |
| 20 | MP0001542_abnormal_bone_strength | 2.02917458 |
| 21 | MP0001819_abnormal_immune_cell | 1.99745381 |
| 22 | MP0003866_abnormal_defecation | 1.99568098 |
| 23 | MP0003724_increased_susceptibility_to | 1.92231097 |
| 24 | MP0003252_abnormal_bile_duct | 1.87865981 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.87740506 |
| 26 | MP0002405_respiratory_system_inflammati | 1.86484832 |
| 27 | MP0005360_urolithiasis | 1.82971175 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.82961359 |
| 29 | MP0000703_abnormal_thymus_morphology | 1.81405295 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.77586374 |
| 31 | MP0002933_joint_inflammation | 1.64385031 |
| 32 | MP0005275_abnormal_skin_tensile | 1.63782045 |
| 33 | MP0000716_abnormal_immune_system | 1.57110032 |
| 34 | MP0002419_abnormal_innate_immunity | 1.54807284 |
| 35 | MP0001790_abnormal_immune_system | 1.53861850 |
| 36 | MP0005387_immune_system_phenotype | 1.53861850 |
| 37 | MP0002398_abnormal_bone_marrow | 1.52567447 |
| 38 | MP0003045_fibrosis | 1.51724427 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.48284427 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.47212477 |
| 41 | MP0006082_CNS_inflammation | 1.44186331 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.41161920 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.40218963 |
| 44 | MP0005410_abnormal_fertilization | 1.38503700 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.37906646 |
| 46 | MP0002722_abnormal_immune_system | 1.37006501 |
| 47 | MP0000685_abnormal_immune_system | 1.34142300 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.33303721 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.32758939 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.25421648 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.25158970 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.25028162 |
| 53 | MP0003011_delayed_dark_adaptation | 1.18649026 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.17396340 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.17362186 |
| 56 | MP0001919_abnormal_reproductive_system | 1.17093454 |
| 57 | MP0002429_abnormal_blood_cell | 1.13540018 |
| 58 | MP0003638_abnormal_response/metabolism_ | 1.11973211 |
| 59 | MP0005389_reproductive_system_phenotype | 1.10736181 |
| 60 | MP0003075_altered_response_to | 1.09639298 |
| 61 | MP0002163_abnormal_gland_morphology | 1.06361300 |
| 62 | MP0005266_abnormal_metabolism | 1.06147527 |
| 63 | MP0003448_altered_tumor_morphology | 1.04654027 |
| 64 | MP0001243_abnormal_dermal_layer | 1.03739239 |
| 65 | MP0002136_abnormal_kidney_physiology | 1.02144654 |
| 66 | MP0001765_abnormal_ion_homeostasis | 0.96744395 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.96424344 |
| 68 | MP0000372_irregular_coat_pigmentation | 0.94548318 |
| 69 | MP0004130_abnormal_muscle_cell | 0.94398648 |
| 70 | MP0005166_decreased_susceptibility_to | 0.93333132 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.91940066 |
| 72 | MP0002693_abnormal_pancreas_physiology | 0.91856104 |
| 73 | MP0001984_abnormal_olfaction | 0.91038447 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.90673955 |
| 75 | MP0003195_calcinosis | 0.90030898 |
| 76 | MP0009643_abnormal_urine_homeostasis | 0.87479712 |
| 77 | MP0005451_abnormal_body_composition | 0.85262408 |
| 78 | MP0001963_abnormal_hearing_physiology | 0.83330633 |
| 79 | MP0008469_abnormal_protein_level | 0.82130592 |
| 80 | MP0002006_tumorigenesis | 0.81452680 |
| 81 | MP0001873_stomach_inflammation | 0.80215792 |
| 82 | MP0002160_abnormal_reproductive_system | 0.79774035 |
| 83 | MP0004142_abnormal_muscle_tone | 0.77385688 |
| 84 | MP0009840_abnormal_foam_cell | 0.74787487 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.74371279 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.74242723 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.72667304 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.70923789 |
| 89 | MP0005647_abnormal_sex_gland | 0.69668179 |
| 90 | MP0003690_abnormal_glial_cell | 0.68588196 |
| 91 | MP0002272_abnormal_nervous_system | 0.68544550 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.68400208 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.68359275 |
| 94 | MP0009764_decreased_sensitivity_to | 0.66527193 |
| 95 | MP0001119_abnormal_female_reproductive | 0.66138254 |
| 96 | MP0005390_skeleton_phenotype | 0.64083101 |
| 97 | MP0000026_abnormal_inner_ear | 0.62460555 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.62381302 |
| 99 | MP0003633_abnormal_nervous_system | 0.58360427 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.55151005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe combined immunodeficiency (HP:0004430) | 6.05639210 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 5.85802962 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.64445942 |
| 4 | T lymphocytopenia (HP:0005403) | 5.56164283 |
| 5 | Abnormality of T cell number (HP:0011839) | 5.27502701 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.01596376 |
| 7 | Aplastic anemia (HP:0001915) | 4.92027141 |
| 8 | Abnormality of T cells (HP:0002843) | 4.86224248 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.76069797 |
| 10 | Thyroiditis (HP:0100646) | 4.68079520 |
| 11 | Pigmentary retinal degeneration (HP:0001146) | 4.30527740 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.30316921 |
| 13 | IgG deficiency (HP:0004315) | 4.30082377 |
| 14 | Chronic diarrhea (HP:0002028) | 4.17252781 |
| 15 | IgM deficiency (HP:0002850) | 4.10161021 |
| 16 | Stomatitis (HP:0010280) | 4.09272229 |
| 17 | Abnormality of B cell number (HP:0010975) | 4.07234108 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 4.00717289 |
| 19 | B lymphocytopenia (HP:0010976) | 3.80800567 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.47814604 |
| 21 | Increased circulating renin level (HP:0000848) | 3.19670610 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.19657075 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.12704078 |
| 24 | Hypoproteinemia (HP:0003075) | 2.92760402 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 2.91812367 |
| 26 | Eczematoid dermatitis (HP:0000976) | 2.85328210 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 2.79598802 |
| 28 | Tetany (HP:0001281) | 2.78454304 |
| 29 | Lymphopenia (HP:0001888) | 2.76954957 |
| 30 | Hypomagnesemia (HP:0002917) | 2.74574774 |
| 31 | Abnormality of eosinophils (HP:0001879) | 2.74425259 |
| 32 | Lymphoma (HP:0002665) | 2.71834084 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70138095 |
| 34 | Spondylolisthesis (HP:0003302) | 2.61066792 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59087580 |
| 36 | Abnormal drinking behavior (HP:0030082) | 2.52886706 |
| 37 | Polydipsia (HP:0001959) | 2.52886706 |
| 38 | Vasculitis (HP:0002633) | 2.44502919 |
| 39 | Large eyes (HP:0001090) | 2.40926269 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.39757979 |
| 41 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39672896 |
| 42 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.39672896 |
| 43 | Abnormal protein glycosylation (HP:0012346) | 2.39672896 |
| 44 | Abnormal glycosylation (HP:0012345) | 2.39672896 |
| 45 | Mesangial abnormality (HP:0001966) | 2.38457474 |
| 46 | Wrist flexion contracture (HP:0001239) | 2.38159326 |
| 47 | Obstructive lung disease (HP:0006536) | 2.36993406 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36993406 |
| 49 | Abnormality of magnesium homeostasis (HP:0004921) | 2.35850099 |
| 50 | Micronodular cirrhosis (HP:0001413) | 2.33273108 |
| 51 | Nonimmune hydrops fetalis (HP:0001790) | 2.23633708 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.18330057 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.17226378 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12444183 |
| 55 | Recurrent sinusitis (HP:0011108) | 2.08917725 |
| 56 | Eosinophilia (HP:0001880) | 2.06972189 |
| 57 | Leukocytosis (HP:0001974) | 2.05867889 |
| 58 | Polyuria (HP:0000103) | 2.05355473 |
| 59 | Abnormality of the renal collecting system (HP:0004742) | 2.03889958 |
| 60 | Alkalosis (HP:0001948) | 2.03572001 |
| 61 | Genetic anticipation (HP:0003743) | 2.01862085 |
| 62 | Dysphonia (HP:0001618) | 2.01637643 |
| 63 | Hypokalemic alkalosis (HP:0001949) | 2.01240882 |
| 64 | Pancytopenia (HP:0001876) | 2.00958419 |
| 65 | Congenital stationary night blindness (HP:0007642) | 2.00851173 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.00301024 |
| 67 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97437524 |
| 68 | Large for gestational age (HP:0001520) | 1.95601338 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93859364 |
| 70 | Chest pain (HP:0100749) | 1.92923811 |
| 71 | Metaphyseal dysplasia (HP:0100255) | 1.90721627 |
| 72 | Subacute progressive viral hepatitis (HP:0006572) | 1.90265273 |
| 73 | Abnormality of chloride homeostasis (HP:0011422) | 1.88169272 |
| 74 | Increased corneal curvature (HP:0100692) | 1.87178467 |
| 75 | Keratoconus (HP:0000563) | 1.87178467 |
| 76 | Hepatocellular necrosis (HP:0001404) | 1.86069285 |
| 77 | Abnormality of the aortic arch (HP:0012303) | 1.86034256 |
| 78 | Recurrent viral infections (HP:0004429) | 1.85253464 |
| 79 | Abnormal spermatogenesis (HP:0008669) | 1.85127922 |
| 80 | Mitochondrial inheritance (HP:0001427) | 1.83718282 |
| 81 | Stomach cancer (HP:0012126) | 1.82894628 |
| 82 | Abnormal urine output (HP:0012590) | 1.81352744 |
| 83 | Metabolic alkalosis (HP:0200114) | 1.79451445 |
| 84 | Gangrene (HP:0100758) | 1.76886578 |
| 85 | Hypokalemia (HP:0002900) | 1.76132444 |
| 86 | Amelogenesis imperfecta (HP:0000705) | 1.75192758 |
| 87 | Neutropenia (HP:0001875) | 1.74836797 |
| 88 | Bronchiectasis (HP:0002110) | 1.74464773 |
| 89 | Sensory axonal neuropathy (HP:0003390) | 1.73375938 |
| 90 | Myositis (HP:0100614) | 1.71371271 |
| 91 | Renal salt wasting (HP:0000127) | 1.68619372 |
| 92 | Abnormality of the prostate (HP:0008775) | 1.68419016 |
| 93 | Increased IgE level (HP:0003212) | 1.67666048 |
| 94 | Progressive cerebellar ataxia (HP:0002073) | 1.67528331 |
| 95 | Optic neuritis (HP:0100653) | 1.66984286 |
| 96 | Retrobulbar optic neuritis (HP:0100654) | 1.66984286 |
| 97 | Poor head control (HP:0002421) | 1.66200527 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 1.65939424 |
| 99 | Recurrent otitis media (HP:0000403) | 1.63086163 |
| 100 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.61465789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 6.19112982 |
| 2 | TXK | 5.88840579 |
| 3 | SCYL2 | 5.23576654 |
| 4 | PASK | 4.96900790 |
| 5 | MAP3K12 | 3.61661905 |
| 6 | TAOK3 | 3.58050230 |
| 7 | KDR | 3.12239352 |
| 8 | ZAP70 | 2.96596834 |
| 9 | MAP4K1 | 2.91829796 |
| 10 | TESK1 | 2.55846652 |
| 11 | ITK | 2.49780806 |
| 12 | MAP3K11 | 2.41017935 |
| 13 | CAMKK1 | 2.19378784 |
| 14 | CSK | 1.89089134 |
| 15 | TEC | 1.87423100 |
| 16 | LIMK1 | 1.73511908 |
| 17 | FES | 1.71243167 |
| 18 | NLK | 1.56727180 |
| 19 | ZAK | 1.47404767 |
| 20 | WNK4 | 1.46097488 |
| 21 | SYK | 1.39449904 |
| 22 | RPS6KA4 | 1.39001851 |
| 23 | BTK | 1.38462493 |
| 24 | JAK3 | 1.33921424 |
| 25 | CLK1 | 1.23060831 |
| 26 | ADRBK2 | 1.20109633 |
| 27 | IKBKE | 1.17438876 |
| 28 | LCK | 1.13064660 |
| 29 | RIPK4 | 1.05814238 |
| 30 | TAOK2 | 1.04559555 |
| 31 | MAPK15 | 1.04333599 |
| 32 | TNK2 | 0.97623300 |
| 33 | MST4 | 0.95623511 |
| 34 | LYN | 0.86021644 |
| 35 | BLK | 0.84672896 |
| 36 | RPS6KA5 | 0.79939639 |
| 37 | OXSR1 | 0.79053977 |
| 38 | GRK6 | 0.74558590 |
| 39 | NEK1 | 0.71237496 |
| 40 | PRKCQ | 0.70318514 |
| 41 | CSF1R | 0.67200997 |
| 42 | TLK1 | 0.66888516 |
| 43 | STK39 | 0.62830548 |
| 44 | TBK1 | 0.60822977 |
| 45 | MAP3K3 | 0.60515236 |
| 46 | HCK | 0.59996781 |
| 47 | MAP3K13 | 0.59778670 |
| 48 | PIM1 | 0.56486687 |
| 49 | MAP3K5 | 0.53627681 |
| 50 | CAMK1 | 0.47876058 |
| 51 | FYN | 0.47116926 |
| 52 | JAK1 | 0.46936474 |
| 53 | GRK1 | 0.46567663 |
| 54 | IGF1R | 0.46537485 |
| 55 | IRAK4 | 0.46276531 |
| 56 | MYLK | 0.44305082 |
| 57 | CDK3 | 0.42150169 |
| 58 | FRK | 0.42020049 |
| 59 | MAP2K3 | 0.39231574 |
| 60 | SGK2 | 0.38587854 |
| 61 | SGK3 | 0.37335798 |
| 62 | CAMKK2 | 0.36478022 |
| 63 | MAPK13 | 0.36234994 |
| 64 | GRK5 | 0.35096232 |
| 65 | TYK2 | 0.34865862 |
| 66 | SGK223 | 0.32529825 |
| 67 | SGK494 | 0.32529825 |
| 68 | MAP3K7 | 0.32183757 |
| 69 | WNK1 | 0.32075953 |
| 70 | GRK7 | 0.30649412 |
| 71 | PDGFRB | 0.29985431 |
| 72 | INSR | 0.29043593 |
| 73 | INSRR | 0.28746110 |
| 74 | NUAK1 | 0.28693807 |
| 75 | FGR | 0.24803695 |
| 76 | SGK1 | 0.24414113 |
| 77 | OBSCN | 0.23741238 |
| 78 | PRKCA | 0.20681224 |
| 79 | IKBKB | 0.20480948 |
| 80 | MAP2K4 | 0.19418355 |
| 81 | STK11 | 0.19285167 |
| 82 | TIE1 | 0.19258534 |
| 83 | ADRBK1 | 0.18786270 |
| 84 | AKT3 | 0.17434438 |
| 85 | RIPK1 | 0.16245867 |
| 86 | ROCK1 | 0.15847992 |
| 87 | PRKCB | 0.15368045 |
| 88 | PRKACA | 0.12921994 |
| 89 | PTK2B | 0.12884927 |
| 90 | MAP2K6 | 0.11448260 |
| 91 | DYRK1B | 0.11020748 |
| 92 | MAPKAPK2 | 0.10765108 |
| 93 | PIK3CG | 0.10422680 |
| 94 | DYRK3 | 0.10137190 |
| 95 | CDK19 | 0.09919017 |
| 96 | LRRK2 | 0.09064321 |
| 97 | PIM2 | 0.07964324 |
| 98 | PRKCI | 0.07952773 |
| 99 | PRKCZ | 0.07375840 |
| 100 | CAMK2G | 0.07242991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.47692553 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.63853710 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.04580717 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.98736313 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.70570666 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.66874189 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.41433000 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08267365 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.95844439 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93686304 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89605851 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 1.89423880 |
| 13 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.66387250 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.64546671 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62482370 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61812199 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.55652381 |
| 18 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.53239590 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51295465 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47521245 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37619177 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36259057 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35705790 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32441558 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27816802 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20814235 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20041946 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06517542 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05893959 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05123169 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04113489 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02101827 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98760741 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98138346 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95656099 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95132960 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94781628 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94512919 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94334375 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91990370 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 0.88005620 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83540973 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81252507 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.80516499 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78489480 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78262499 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76511063 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76178462 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73823483 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73465566 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70438887 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.70333972 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69076590 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.66487173 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64376061 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.62691286 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62440509 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.62017597 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60391341 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60236877 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58958844 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58289996 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57924180 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56498656 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54128917 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.53465294 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52275540 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51095256 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50143975 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48627531 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48427780 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47433247 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47388163 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44264451 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44211840 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.44009321 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40353836 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.40033198 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37670146 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.37475870 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35932849 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34436231 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33127212 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.31030562 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30881645 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30041158 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29166856 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.28517753 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27963954 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27457177 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26532698 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.26249596 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26115109 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.24723888 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24305716 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.24072396 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23637566 |
| 98 | RNA polymerase_Homo sapiens_hsa03020 | 0.21415827 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20404476 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.19841347 |

